ArticleOncoimmunology2016

NLRC5 elicits antitumor immunity by enhancing processing and presentation of tumor antigens to CD8(+) T lymphocytes.

Galaxia M Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.